» Articles » PMID: 22508765

Differential DNase I Hypersensitivity Reveals Factor-dependent Chromatin Dynamics

Overview
Journal Genome Res
Specialty Genetics
Date 2012 Apr 18
PMID 22508765
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Transcription factor cistromes are highly cell-type specific. Chromatin accessibility, histone modifications, and nucleosome occupancy have all been found to play a role in defining these binding locations. Here, we show that hormone-induced DNase I hypersensitivity changes (ΔDHS) are highly predictive of androgen receptor (AR) and estrogen receptor 1 (ESR1) binding in prostate cancer and breast cancer cells, respectively. While chromatin structure prior to receptor binding and nucleosome occupancy after binding are strikingly different for ESR1 and AR, ΔDHS is highly predictive for both. AR binding is associated with changes in both local nucleosome occupancy and DNase I hypersensitivity. In contrast, while global ESR1 binding is unrelated to changes in nucleosome occupancy, DNase I hypersensitivity dynamics are also predictive of the ESR1 cistrome. These findings suggest that AR and ESR1 have distinct modes of interaction with chromatin and that DNase I hypersensitivity dynamics provides a general approach for predicting cell-type specific cistromes.

Citing Articles

IGN: Invariable gene set-based normalization for chromatin accessibility profile data analysis.

Hu S, Xue H, Zang C Comput Struct Biotechnol J. 2025; 27:501-507.

PMID: 39931505 PMC: 11808601. DOI: 10.1016/j.csbj.2025.01.018.


Non-coding genetic variants underlying higher prostate cancer risk in men of African ancestry.

Hannenhalli S, Li S, Fatema K, Nidharshan S, Singh A, Rajagopal P Res Sq. 2024; .

PMID: 39678351 PMC: 11643368. DOI: 10.21203/rs.3.rs-5485172/v1.


Relaxin Modulates the Genomic Actions and Biological Effects of Estrogen in the Myometrium.

Tripathy S, Nagari A, Chiu S, Nandu T, Camacho C, Mahendroo M Endocrinology. 2024; 165(11).

PMID: 39283953 PMC: 11462454. DOI: 10.1210/endocr/bqae123.


Relaxin Modulates the Genomic Actions and Biological Effects of Estrogen in the Myometrium.

Tripathy S, Nagari A, Chiu S, Nandu T, Camacho C, Mahendroo M bioRxiv. 2024; .

PMID: 38659934 PMC: 11042280. DOI: 10.1101/2024.04.15.589654.


AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.

Kiliti A, Sharif G, Martin M, Wellstein A, Riegel A Front Endocrinol (Lausanne). 2023; 14:1250218.

PMID: 37711895 PMC: 10498919. DOI: 10.3389/fendo.2023.1250218.


References
1.
Verzi M, Shin H, He H, Sulahian R, Meyer C, Montgomery R . Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. Dev Cell. 2010; 19(5):713-26. PMC: 3001591. DOI: 10.1016/j.devcel.2010.10.006. View

2.
Joseph R, Orlov Y, Huss M, Sun W, Kong S, Ukil L . Integrative model of genomic factors for determining binding site selection by estrogen receptor-α. Mol Syst Biol. 2010; 6:456. PMC: 3018168. DOI: 10.1038/msb.2010.109. View

3.
Irizarry R, Hobbs B, Collin F, Beazer-Barclay Y, Antonellis K, Scherf U . Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003; 4(2):249-64. DOI: 10.1093/biostatistics/4.2.249. View

4.
Lanz R, Bulynko Y, Malovannaya A, Labhart P, Wang L, Li W . Global characterization of transcriptional impact of the SRC-3 coregulator. Mol Endocrinol. 2010; 24(4):859-72. PMC: 2852354. DOI: 10.1210/me.2009-0499. View

5.
Siersbaek R, Nielsen R, John S, Sung M, Baek S, Loft A . Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J. 2011; 30(8):1459-72. PMC: 3102274. DOI: 10.1038/emboj.2011.65. View